Overview
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Industry
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
Declarations of will on behalf of the company require joint action by two members of the management board, including at least one member of the management board appointed by Lesław Lenartowicz, Cezary Oktaba or Piotr Kister, i.e. in accordance with § 14 section 3 points 1–3 of the company's articles of association, and at least one member of the management board appointed by Affidea Onkoterapia sp. z o.o., i.e. in accordance with § 14 section 3 point 4 of the company's articles of association. The company's management board is appointed by the partners in such a way that Lesław Lenartowicz, Cezary Oktaba and Piotr Kister each appoint one member of the management board, and Affidea Onkoterapia sp. z o.o. appoints four members of the management board. From among the members of the management board, Piotr Kister appoints the President of the Management Board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 71 | $958.94 | 71% | |
Piotr Michał Kister (53) | 13 | $175.58 | 13% |
Lesław Kazimierz Lenartowicz (70) | 10 | $135.06 | 10% |
Others | 6 | $81.04 | 6% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Ségolène Francine M Frère (49)  | Osoba fizyczna sprawująca kontrolę nad osobą prawną, której przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów | |
Piotr Michał Kister (53)  | Shareholder of a limited liability company, 650.0 PLN | |
Lesław Kazimierz Lenartowicz (70) | Shareholder of a limited liability company, 500.0 PLN | |
Cezary Ireneusz Oktaba (66) | Shareholder of a limited liability company, 300.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ScanmedS.A. | $266,523,177.15 | scanmed.pl | ||
| LUX Med Onkologiasp. z o.o. | $121,974,338.96 | onkologia.luxmed.pl | ||
| Szpital Wolski Im. Dr Anny Gostyńskiejsp. z o.o. | $66,853,476.48 | wolski.med.pl | ||
| Szpital Czerniakowskisp. z o.o. | $53,133,134.99 | szpitalczerniakowski.waw.pl | ||
| Sawimedsp. z o.o. | $4,507,040.08 | sawimed.pl | ||
| Ortopedikasp. z o.o. | $3,201,651.04 | ortopedika.pl | ||
| SensinS.A. | $995,005.39 | sensinclinic.pl | ||
| Ackermann Caresp. z o.o. | $440,920.71 | ackermann.agency | ||
| Centrum Badań Medycznych Brand Medsp. z o.o. | $66,160.01 | brand-med.pl | ||
| Affidea Onkoterapiasp. z o.o. | — | affidea.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-12-04 | Address change (Ul. Józefa I Jana Rostafińskich 4, 02-593, Warszawa → Plac Europejski 2, 00-844, Warszawa) | |
| 2023-04-28 | Entered in the register |
FAQ
Last updated: 2026-04-22